Zhao, Y., Liu, X., Wang, L., Pan, X., Pan, F. and Ke, Q. 2024. MiR-302 targets PAK5 and prevents the transition from chronic hepatitis B to liver cirrhosis. Journal of the Pakistan Medical Association. 74, 12 (Nov. 2024), 2114–2121. DOI:https://doi.org/10.47391/JPMA.11128.